Compound details
5,6-Dihydro-11-methoxyyangonin
| Compound ID | CDAMM02434 |
|---|---|
| Common name | 5,6-Dihydro-11-methoxyyangonin | IUPAC name | 2-[2-(3,4-dimethoxyphenyl)ethenyl]-4-methoxy-2,3-dihydropyran-6-one |
| Molecular formula | C16H18O5 |
| Retention time | 5.48 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 291.123 | Theoretical mz | 291.122 |
| Error | 2.49 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.3868 |
| Inchi key | FISBBPCLKKQWQA-XQRVVYSFNA-N |
|---|---|
| Smiles | O=C1OC(C=CC2=CC=C(OC)C(OC)=C2)CC(OC)=C1 |
| Superclass | Phenylpropanoids and polyketides |
| Class | Kavalactones |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P05067 | APP | Beta amyloid A4 protein | T87024 | SEA |
| P11926 | ODC1 | Ornithine decarboxylase | T60366 | SEA |
| P11474 | ESRRA | Estrogen-related receptor alpha | T72841 | SEA |
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | T83145 | SEA |
| P11388 | TOP2A | DNA topoisomerase II alpha | T17048 | SEA |
| Q9UNQ0 | ABCG2 | ATP-binding cassette sub-family G member 2 | T56556 | SEA |
| Q16678 | CYP1B1 | Cytochrome P450 1B1 | T92521 | SEA |
| P10636 | MAPT | Microtubule-associated protein tau | T45593 | SEA |
| Q04760 | GLO1 | Glyoxalase I | T88285 | SEA |
| P19438 | TNFRSF1A | Tumor necrosis factor receptor R1 | T86552 | SEA |
| Q16236 | NFE2L2 | Nuclear factor erythroid 2-related factor 2 | T88505 | SEA |
| Q9H4B7 | TUBB1 | Tubulin beta-1 chain | T84397 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T87024 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P05067 | APP |
| T87024 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P05067 | APP |
| T60366 | DI0020 | African trypanosomiasis | [ICD-11: 1F51] | P11926 | ODC1 |
| T72841 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P11474 | ESRRA |
| T83145 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P19838 | NFKB1 |
| T83145 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P19838 | NFKB1 |
| T17048 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11388 | TOP2A |
| T17048 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P11388 | TOP2A |
| T17048 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11388 | TOP2A |
| T56556 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9UNQ0 | ABCG2 |
| T56556 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UNQ0 | ABCG2 |
| T45593 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10636 | MAPT |
| T45593 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P10636 | MAPT |
| T45593 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P10636 | MAPT |
| T88285 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | Q04760 | GLO1 |
| T86552 | DI0060 | Brain cancer | [ICD-11: 2A00] | P19438 | TNFRSF1A |
| T86552 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P19438 | TNFRSF1A |
| T88505 | DI0038 | Ataxic disorder | [ICD-11: 8A03] | Q16236 | NFE2L2 |
| T84397 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9H4B7 | TUBB1 |